These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 21160860)

  • 1. Molecular regulation of vasculogenic mimicry in tumors and potential tumor-target therapy.
    Fan YZ; Sun W
    World J Gastrointest Surg; 2010 Apr; 2(4):117-27. PubMed ID: 21160860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Overview of Vasculogenic Mimicry in Breast Cancer.
    Andonegui-Elguera MA; Alfaro-Mora Y; Cáceres-Gutiérrez R; Caro-Sánchez CHS; Herrera LA; Díaz-Chávez J
    Front Oncol; 2020; 10():220. PubMed ID: 32175277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors.
    Hernández de la Cruz ON; López-González JS; García-Vázquez R; Salinas-Vera YM; Muñiz-Lino MA; Aguilar-Cazares D; López-Camarillo C; Carlos-Reyes Á
    Front Oncol; 2019; 9():1419. PubMed ID: 31993365
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of advances in vasculogenic mimicry - a potential target for tumor therapy.
    Ge H; Luo H
    Cancer Manag Res; 2018; 10():2429-2437. PubMed ID: 30122992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signaling pathways in tumor vasculogenic mimicry.
    Vartanian AA
    Biochemistry (Mosc); 2012 Sep; 77(9):1044-55. PubMed ID: 23157265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of Thrombospondin-2 modulates tumor vasculogenic mimicry by PI3K/AKT/mTOR signaling pathway.
    Huang J; Wang C; Hou Y; Tian Y; Li Y; Zhang H; Zhang L; Li W
    Biomed Pharmacother; 2023 Nov; 167():115455. PubMed ID: 37696083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advanced research on vasculogenic mimicry in cancer.
    Qiao L; Liang N; Zhang J; Xie J; Liu F; Xu D; Yu X; Tian Y
    J Cell Mol Med; 2015 Feb; 19(2):315-26. PubMed ID: 25598425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets.
    Mao JM; Liu J; Guo G; Mao XG; Li CX
    Biomark Res; 2015; 3():8. PubMed ID: 26085929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor cell vascular mimicry: Novel targeting opportunity in melanoma.
    Hendrix MJ; Seftor EA; Seftor RE; Chao JT; Chien DS; Chu YW
    Pharmacol Ther; 2016 Mar; 159():83-92. PubMed ID: 26808163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histochemical Staining of Vasculogenic Mimicry.
    Imani S; Liu S; Maghsoudloo M; Wen Q
    Methods Mol Biol; 2022; 2514():107-120. PubMed ID: 35771423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular Mechanisms and Anticancer Therapeutic Strategies in Vasculogenic Mimicry.
    Zhang X; Zhang J; Zhou H; Fan G; Li Q
    J Cancer; 2019; 10(25):6327-6340. PubMed ID: 31772665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Research progress in vasculogenic mimicry in 
multiple tumors].
    Bai J; Xu Z; Liao C; Yang L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Mar; 42(3):357-364. PubMed ID: 28364113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
    Aikins AR; Kim M; Raymundo B; Kim CW
    Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 enhances tumor aggressiveness by promoting tumor cell plasticity.
    Paulis YW; Huijbers EJ; van der Schaft DW; Soetekouw PM; Pauwels P; Tjan-Heijnen VC; Griffioen AW
    Oncotarget; 2015 Aug; 6(23):19634-46. PubMed ID: 26189059
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasculogenic Mimicry-An Overview.
    Marques Dos Reis E; Vieira Berti F
    Methods Mol Biol; 2022; 2514():3-13. PubMed ID: 35771413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular regulation of vasculogenic mimicry in human uveal melanoma cells: role of helix-loop-helix Id2 (inhibitor of DNA binding 2).
    Su F; Li B; Wang J; Xu X; Ren R; Li L; Gao F; Liu X
    Graefes Arch Clin Exp Ophthalmol; 2009 Mar; 247(3):411-9. PubMed ID: 19043732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances and Prospects of Vasculogenic Mimicry in Glioma: A Potential New Therapeutic Target?
    Cai H; Liu W; Liu X; Li Z; Feng T; Xue Y; Liu Y
    Onco Targets Ther; 2020; 13():4473-4483. PubMed ID: 32547078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments.
    Wei X; Chen Y; Jiang X; Peng M; Liu Y; Mo Y; Ren D; Hua Y; Yu B; Zhou Y; Liao Q; Wang H; Xiang B; Zhou M; Li X; Li G; Li Y; Xiong W; Zeng Z
    Mol Cancer; 2021 Jan; 20(1):7. PubMed ID: 33397409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vasculogenic mimicry in carcinogenesis and clinical applications.
    Luo Q; Wang J; Zhao W; Peng Z; Liu X; Li B; Zhang H; Shan B; Zhang C; Duan C
    J Hematol Oncol; 2020 Mar; 13(1):19. PubMed ID: 32169087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of Vasculogenic Mimicry in Ovarian Cancer.
    Ayala-Domínguez L; Olmedo-Nieva L; Muñoz-Bello JO; Contreras-Paredes A; Manzo-Merino J; Martínez-Ramírez I; Lizano M
    Front Oncol; 2019; 9():998. PubMed ID: 31612116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.